News

The submission is expected to take place in the third quarter of 2014 based on discussions with the FDA regarding the final results of PALOMA-1, a randomized, Phase

The open-label trial involved 12 CIS patients recruited from sites in the US to examine the efficacy of Vesimune over six doses. The trial population included both BCG

GELESIS100 is a smart pill that is designed to treat the physiological symptoms of hunger without surgery, invasive procedures or systemic absorption. To date, Gelesis100 has generated compelling

Their findings have been published in the February issue of Hepatology, 2014. This medical discovery has opened up a brand new chapter in explaining the mechanism of Hepatitis

Pirfenidone is an investigational therapy in the US and has not been approved by the US Food and Drug Administration (FDA). Expanded access programs provide a mechanism for

The distribution center represents a significant capacity upgrade in DKSH’s healthcare infrastructure in Malaysia. The new facility in Hicom Industrial Estate, Shah Alam replaces DKSH Malaysia’s older Central

The Bill & Melinda Gates Foundation joins existing investor, the Wellcome Trust, each investing $20m. The funds will enable Kymab to maximise the potential of its Kymouse platform

The new business will become Horizon CombinatoRx Incorporated, a wholly owned subsidiary of Horizon. Horizon CombinatoRx will provide access to the unique cHTS platform and Chalice analytics software,

Candesartan ASKA is an authorized generic (AG) of Blopress (candesartan cilexetil), which Takeda has licensed the patent to Aska. Aska had received approval for the drug from the